Echo currently has partnering opportunities in the following areas:
Prelude® Skin Prep System patented, core controlled-feedback skin permeation technology.
Symphony® tCGM System non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system for use in ICU, hospitals, or in a home-use setting.
Durhalieve topical AzoneTSTM reformulation of triamcinolone acetonide for treatment of corticosteroid-responsive dermatoses.
For further information on partnering with Echo please contact us at .